death

My Life As A Science Experiment ; Continues

Source Node:
Time Stamp: September 11, 2023 1:04 PM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

  A year ago Every=Ten of Ten doctors told me with confidence that I would Not get better and could not survive with Kidney function of 4.1% and Creatinine of 12.32. Immediate dialysis leading to a hopeful transplant or; death. I rejected every doctors advice and had this idea that for as long as I can I would reverse engineer manually all the vital functions that kidneys influence. It's 13 months later and I function well using frequent blood tests to tweak my protocol. It's a 24/7 job with 20+

My Health Manifesto : Cracking The Code : Flying Solo

Source Node:
Time Stamp: September 11, 2023 12:37 PM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

  Today when I Google "how long can a person live with my GFR 5% / kidney function the answer was "a few hours to a few weeks without dialysis." In a study with 8000+ patients 65+ with similar numbers; a month was the survival time. @68 (Stage 5 kidney failure is less than 15% /GFR; I'm not even anywhere on/near the chart) As I enter my Fourteenth/14th month; I am Defiantly hopeful. positive and optimistic that My Miracle will continue. #notmytimetodie #superoutlier While I challenge this death sentence I feel better and

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:22 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating